← Back
$ATHA All transactions

Athira Pharma, Inc.

A

$ Value

$0

Shares

133,526

Price

$0

Filed

Dec 29

Insider

Name

Litton Mark James

Title

President and CEO

CIK

0001604834

Roles

Director Officer

Transaction Details

Transaction Date

2025-12-24

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

133,526

Footnotes

The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant. | On September 25, 2025, the reporting person was granted an option to purchase 133,526 shares of common stock. The option was scheduled to vest only upon satisfaction of both a milestone requirement (the "Milestone Requirement") and a service-based requirement (the "Service-Based Requirement"). The Milestone Requirement was satisfied on December 23, 2025. The Service-Based Requirement will be satisfied as to 50% of the total number of shares granted under the option on December 23, 2026 and as to 1/36th of the remaining 50% on the 23rd day of each month thereafter, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan) through the applicable vesting dates.

Filing Info

Accession No.

0001604834-25-000004

Form Type

4

Issuer CIK

0001620463

Litton Mark James's History

Date Ticker Type Value
2026-04-09 LONA A $0
2026-03-04 LONA $28K
2026-03-03 LONA M $0
2026-03-03 LONA M $0
2026-01-02 ATHA $18K
2025-12-31 ATHA M $0
2025-12-31 ATHA M $0
2025-12-24 ATHA A $0
2025-07-01 ATHA $7K
2025-06-30 ATHA M $0

Other Insiders at ATHA (90d)

Insider Bought Sold Last
EDELMAN JOSEPH 2026-04-09
FLUKE JOHN M JR 2026-04-09
JOHNSON JAMES A 2026-04-09
PICKERING GRANT 2026-04-09
Litton Mark James
PRESIDENT and CEO
$28K 2026-04-09
Panzara Michael A. 2026-04-09
Romano Kelly A 2026-04-09
Kosacz Barbara 2026-04-09
San Martin Javier
CHIEF MEDICAL OFFICER
$9K 2026-04-09
CHURCH KEVIN
CHIEF SCIENTIFIC OFFICER
$7K 2026-04-09
Worthington Mark
GENERAL COUNSEL and CCO
$7K 2026-04-09
Renninger Robert
CHIEF FINANCIAL OFFICER
$5K 2026-04-09